Anna L. Stratford

Phosphorylated Insulin-Like Growth Factor-I/Insulin Receptor Is Present in All Breast Cancer Subtypes and Is Related to Poor Survival

Jennifer Law, Golareh Habibi, Kaiji Hu et al. · Cancer Research · 2008 · 408 citations · Full text

Life Sciences, Cancer Biology, Oncology +14

Vascular Endothelial Growth Factor, Its Receptor KDR/Flk-1, and Pituitary Tumor Transforming Gene in Pituitary Tumors

Christopher J. McCabe, Kristien Boelaert, Lesley Tannahill et al. · The Journal of Clinical Endocrinology & Metabolism · 2002 · 216 citations · Full text

Medicine, Endocrinology, Molecular Biology +17

Y-Box Binding Protein-1 Induces the Expression of <i>CD44</i> and <i>CD49f</i> Leading to Enhanced Self-Renewal, Mammosphere Growth, and Drug Resistance

Karen To, Abbas Fotovati, Kristen M. Reipas et al. · Cancer Research · 2010 · 168 citations · Full text

Medicine, Molecular Biology, Oncology +17

Y-box binding protein-1 serine 102 is a downstream target of p90 ribosomal S6 kinase in basal-like breast cancer cells

Anna L. Stratford, Christopher J. Fry, Curtis Desilets et al. · Breast Cancer Research · 2008 · 165 citations · Full text

Life Sciences, Molecular Biology, Oncology +15

Epidermal growth factor receptor (EGFR) is transcriptionally induced by the Y-box binding protein-1 (YB-1) and can be inhibited with Iressa in basal-like breast cancer, providing a potential target for therapy

Anna L. Stratford, Golareh Habibi, Arezoo Astanehe et al. · Breast Cancer Research · 2007 · 145 citations · Full text

Medicine, Cancer Biology, Oncology +17